Pfizer to Merge Its Off-Patent Drug Unit With Mylan The New York Times
Pfizer agreed on Monday to combine its off-patent drugs division, which sells treatments like the cholesterol drug Lipitor, with the pharmaceutical company Mylan …
Pfizer to Merge Its Off-Patent Drug Unit With Mylan The New York Times
Pfizer agreed on Monday to combine its off-patent drugs division, which sells treatments like the cholesterol drug Lipitor, with the pharmaceutical company Mylan …